Back to Search
Start Over
Evaluation of Cobas Core Rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles
- Source :
- Journal of Clinical Microbiology. 33:2392-2394
- Publication Year :
- 1995
- Publisher :
- American Society for Microbiology, 1995.
-
Abstract
- Cobas Core Rubella IgG EIA recomb (Roche), a new, commercially available rubella enzyme immunoassay using recombinant rubella-like particles, was compared with a hemagglutination inhibition assay (Rubenosticon; Organon Teknika) and two whole-virus enzyme immunoassays (IMx [Abbott] and Platelia [Sanofi Diagnostics Pasteur]). Compared with those of these reference assays, the relative sensitivities of Cobas Core Rubella IgG recomb were 100, 94, and 95.9%, with specificities amounting to 80.8, 98, and 98.2%, respectively.
- Subjects :
- Microbiology (medical)
Biology
Antibodies, Viral
Rubella
law.invention
Immunoenzyme Techniques
Viral Proteins
fluids and secretions
law
parasitic diseases
medicine
Humans
chemistry.chemical_classification
Hemagglutination assay
medicine.diagnostic_test
Rubella diagnosis
medicine.disease
Virology
Molecular biology
Recombinant Proteins
Enzyme
chemistry
Immunoenzyme techniques
Immunoassay
Recombinant DNA
Enzyme immunoassays
Rubella virus
Research Article
Subjects
Details
- ISSN :
- 1098660X and 00951137
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Microbiology
- Accession number :
- edsair.doi.dedup.....c7c7b8390e6201a977004a35d60cb634